Opinion
2012-1131 2012-1195
05-21-2012
NOTE: This order is nonprecedential.
Appeal from the United States District Court for the District of New Jersey in case no. 09-CV-5283, Judge Esther Salas.
Appeal from the United States District Court for the District of New Jersey in case no. 11-CV-1192, Judge Esther Salas.
ON MOTION
ORDER
Hoffmann-La Roche Inc. moves to consolidate the above-captioned appeals. Teva Pharmaceuticals USA, Inc. et al. (Teva) oppose. Accord Healthcare Inc. et al. (Accord) oppose consolidation and move to stay appeal no. 2012-1195 pending appeal no. 2012-1131 stating they agree to be bound by this court's decision in 2012-1131. Hoffmann-La Roche replies and consents to a stay of 2012-1195. Hoffmann-La Roche moves for an extension of time, until May 9, 2012, to file its opening brief in 2012-1131. Teva opposes. Hoffmann La Roche replies. Hoffmann La Roche also moves without opposition for an extension of time to file its opening brief in 2012-1195.
Hoffmann La Roche also moved to consolidate these appeals with Hoffmann-La Roche v. Roxane Labs, No. 2012-1132, but this court subsequently granted Hoffmann LaRoche's motion to voluntarily dismiss that appeal.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) The motion to consolidate is denied.
(2) Appeal no. 2012-1195 is stayed pending issuance of the mandate in appeal no. 2012-1131. Within 14 days thereof, Hoffmann La Roche and Accord are directed to inform this court concerning how they believe 2012-1195 should proceed.
(3) A copy of this order will be forwarded to the merits panel in appeal no. 2012-1131.
(4) Hoffmann La Roche's motion for an extension of time is granted.
(5) Teva shall calculate the due date for its response brief from the date of filing of this order.
(6) Hoffmann La Roche's motion for an extension of time in 2012-1195 is moot in light of the stay.
FOR THE COURT cc: Brian D. Coggio, Esq.
Jeffer Ali, Esq.
Kenneth G. Schuler, Esq.
Michael R. Dzwonczyk, Esq.
s25
______________
Jan Horbaly
Clerk